Check-Cap Ltd (7CC) - Total Assets
Based on the latest financial reports, Check-Cap Ltd (7CC) holds total assets worth €7.49 Million EUR (≈ $8.75 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Check-Cap Ltd to assess how comfortably operating cash covers total debt obligations.
Check-Cap Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Check-Cap Ltd's total assets have evolved over time, based on quarterly financial data. See 7CC total equity for net asset value and shareholders' equity analysis.
Check-Cap Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Check-Cap Ltd's total assets of €7.49 Million consist of 2.9% current assets and 97.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.0% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Check-Cap Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Check-Cap Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Check-Cap Ltd's current assets represent 2.9% of total assets in 2025, a decrease from 96.6% in 2016.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 94.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Check-Cap Ltd Competitors by Total Assets
Key competitors of Check-Cap Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
Indonesia | Rp2.57 Trillion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
Check-Cap Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.15 | 6.18 |
| Quick Ratio | 0.05 | 0.15 | 6.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.83 Million | €-1.55 Million | €15.44 Million |
Check-Cap Ltd - Advanced Valuation Insights
This section examines the relationship between Check-Cap Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.95 |
| Latest Market Cap to Assets Ratio | 0.98 |
| Asset Growth Rate (YoY) | 1885.7% |
| Total Assets | €7.49 Million |
| Market Capitalization | $7.30 Million USD |
Valuation Analysis
Near Book Valuation: The market values Check-Cap Ltd's assets close to their book value (0.98x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Check-Cap Ltd's assets grew by 1885.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Check-Cap Ltd (2016–2025)
The table below shows the annual total assets of Check-Cap Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €7.49 Million ≈ $8.75 Million |
+1885.68% |
| 2024-12-31 | €377.00K ≈ $440.75K |
-98.49% |
| 2023-12-31 | €25.02 Million ≈ $29.25 Million |
-44.95% |
| 2022-12-31 | €45.44 Million ≈ $53.13 Million |
-18.36% |
| 2021-12-31 | €55.66 Million ≈ $65.07 Million |
+183.42% |
| 2020-12-31 | €19.64 Million ≈ $22.96 Million |
+108.27% |
| 2019-12-31 | €9.43 Million ≈ $11.02 Million |
-38.92% |
| 2018-12-31 | €15.44 Million ≈ $18.05 Million |
+95.24% |
| 2017-12-31 | €7.91 Million ≈ $9.24 Million |
-35.70% |
| 2016-12-31 | €12.29 Million ≈ $14.37 Million |
-- |
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.